Achilles Anagnostopoulos

Chief Scientific Director

Greece

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Achilles Anagnostopoulos is the Chief Scientific Director at TheraCell Laboratories in Greece. His research interests encompass allogeneic hematopoietic stem cell transplantation, viral reactivation monitoring, and the clinical applicability of novel T-cell therapies. Notable recent contributions include studies on infection prophylaxis in immunocompromised patients and the impact of specific genetic markers on COVID-19 severity.

Articles (16)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Timoleon-Achilleas Vyzantiadis

Aristotle University of Thessaloniki

GREECE

View details

Grzegorz Władysław Basak

University Clinical Centre

POLAND

View details

Per Ljungman

Karolinska University Hospital

SWEDEN

View details

Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

Anastasia Papadopoulou

Assistant Professor of Immunobiology

Aristotle University of Thessaloniki

GREECE

View details

Argiris Symeonidis

Professor of Hematology, Head of the Department

University of Patras School of Medicine

GREECE

View details

Fani Chatzopoulou

Aristotle University of Thessaloniki

GREECE

View details

Maria Gavriilaki

AHEPA University Hospital

GREECE

View details

Eleni Gavriilaki

Aristotle University of Thessaloniki

GREECE

View details

Panagiotis Τ. Diamantopoulos

National and Kapodistrian University of Athens

GREECE

View details

Vasilios Kimiskidis

Professor

Aristotle University of Thessaloniki

GREECE

View details

Dimitrios Kazis

Aristotle University of Thessaloniki

GREECE

View details

Charalampos Pontikoglou

Associate Professor of Hematology

University of Crete

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Achilles Anagnostopoulos

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation.

The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms

Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.

Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Robust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot

The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients

Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML

Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion‐dependent β‐thalassaemia of a severe genotype

Collaborators (13)

Timoleon-Achilleas Vyzantiadis

Grzegorz Władysław Basak

Per Ljungman

Ibrahim Yakoub-Agha

Anastasia Papadopoulou

Argiris Symeonidis

Fani Chatzopoulou

Maria Gavriilaki

Eleni Gavriilaki

Panagiotis Τ. Diamantopoulos

Vasilios Kimiskidis

Dimitrios Kazis

Charalampos Pontikoglou

Make your next move.